Johnson & Johnson (JNJ) Other Non-Current Liabilities (2009 - 2026)

Johnson & Johnson has reported Other Non-Current Liabilities for 18 years, with the latest figure at $10.1 billion in Q2 2026.

• Quarterly Other Non-Current Liabilities rose 773.03% year-over-year to $10.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.1 billion (up 773.03% YoY) and the FY2025 annual result came in at $9.9 billion, up 710.85% from the prior year.
• Other Non-Current Liabilities declined to $10.1 billion in Q2 2026 per JNJ's latest filing, from $10.2 billion in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $10.2 billion in Q1 2026 and troughed at $486.0 million in Q2 2022.
• A 5-year average of $2.9 billion and a median of $1.2 billion in 2025 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities decreased 19.0% in 2022, then jumped 773.03% in 2026.
• Over 5 years, Other Non-Current Liabilities stood at $525.0 million in 2022, then jumped by 108.0% to $1.1 billion in 2023, then climbed by 11.45% to $1.2 billion in 2024, then soared by 710.85% to $9.9 billion in 2025, then increased by 2.36% to $10.1 billion in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $10.1 billion, $10.2 billion, and $9.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.